Related Experiment Video
Updated: May 10, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
C2ORF40 suppresses breast cancer cell proliferation and invasion through modulating expression of M phase cell cycle
Jing Lu1, Mingxin Wen, Yurong Huang
1Department of Anatomy and Key Laboratory of Experimental Teratology; Ministry of Education; Shandong University School of Medicine; Jinan, Shandong, P.R. China.
Abstract:
Recently, it has been suggested that C2ORF40 is a candidate tumor suppressor gene in breast cancer. However, the mechanism for reduced expression of C2ORF40 and its functional role in breast cancers remain unclear. Here we show that C2ORF40 is frequently silenced in human primary breast cancers and cell lines through promoter hypermethylation. C2ORF40 mRNA level is significantly associated with patient disease-free survival and distant cancer metastasis. Overexpression of C2ORF4 0 inhibits breast cancer cell proliferation, migration and invasion. By contrast, silencing C2ORF40 expression promotes these biological phenotypes. Bioinformatics and FACS analysis reveal C2ORF40 functions at G2/M phase by downregulation of mitotic genes expression, including UBE2C. Our results suggest that C2ORF40 acts as a tumor suppressor gene in breast cancer pathogenesis and progression and is a candidate prognostic marker for this disease.
Insights
C2ORF40 acts as a tumor suppressor in breast cancer by silencing gene expression via promoter hypermethylation. Its reduced levels correlate with poor prognosis, inhibiting cancer cell growth and metastasis.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- C2ORF40 is a potential tumor suppressor in breast cancer.
- The mechanisms of C2ORF40 downregulation and its precise function in breast cancer are not fully understood.
Purpose of the Study:
- To investigate the mechanism of C2ORF40 silencing in breast cancer.
- To elucidate the functional role of C2ORF40 in breast cancer progression.
- To evaluate C2ORF40 as a prognostic marker.
Main Methods:
- Analysis of C2ORF40 expression and promoter methylation in human breast cancers and cell lines.
- Functional studies involving C2ORF40 overexpression and silencing in breast cancer cells.
- Bioinformatics and Fluorescence-Activated Cell Sorting (FACS) analysis.
Main Results:
- C2ORF40 is frequently silenced in breast cancers due to promoter hypermethylation.
- Lower C2ORF40 mRNA levels are linked to reduced disease-free survival and increased distant metastasis.
- C2ORF40 overexpression inhibits cell proliferation, migration, and invasion, while its silencing promotes these phenotypes.
- C2ORF40 regulates cell cycle at the G2/M phase by downregulating mitotic genes like UBE2C.
Conclusions:
- C2ORF40 functions as a tumor suppressor in breast cancer development and progression.
- C2ORF40 is a potential prognostic biomarker for breast cancer patients.
More Related Videos
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Negative Regulator Molecules

